Reducing heart disease risk in people with opioid use disorder
Lowering Cardiovascular Disease Among People with Opioid Use Disorder
This study is looking at why people with opioid use disorder often have heart problems, especially high blood pressure, and how we can help them get the treatment they need by understanding their challenges and improving support from healthcare providers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-11114620 on NIH RePORTER |
What this research studies
This research investigates the high rates of cardiovascular disease (CVD) among individuals with opioid use disorder (OUD), focusing on hypertension as a key risk factor. It aims to understand the barriers that prevent this population from receiving necessary hypertension treatment and to explore how healthcare providers can better support them. By gathering insights from both patients and healthcare providers, the study seeks to identify effective strategies for integrating cardiovascular disease prevention into addiction treatment settings. The research will also evaluate the impact of Medicaid programs on improving care coordination for individuals with OUD.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults aged 21 and older who are diagnosed with opioid use disorder and may also have hypertension.
Not a fit: Patients who do not have opioid use disorder or those under 21 years old may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved cardiovascular health and reduced mortality rates among individuals with opioid use disorder.
How similar studies have performed: Previous research has shown that addressing cardiovascular risk factors in high-risk populations can lead to significant health improvements, indicating potential success for this approach.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Shuey, Bryant — University of Pittsburgh at Pittsburgh
- Study coordinator: Shuey, Bryant
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.